Square stock had a strong run up in 2020 with year to date returns of 247.84%, and currently it is trading at a price to sales ratio of 14, and price to earnings ratio of 310. Such nose bleed valuations implies that high growth expectations has been baked into the stock and investors are betting on the company to deliver stellar growth. When I added Square When the news of the discovery of Covid 19 vaccine broke, there has been a slow rotation of ‘work from home’ stocks to ‘back to office’ stocks and I took the opportunity nibble some Square shares with the hope to increase my position as it drops further. Unfortunately, the dip was short lived, and currently Square is just $18.7 away from its all time high of $241.58. After doing some research, I decided to add a few more shares near its high as I believe there is still plenty of growth remaining....